KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 252 filers reported holding KITE PHARMA INC in Q3 2017. The put-call ratio across all filers is 1.40 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $1,443,000 | +73.4% | 8,025 | 0.0% | 0.01% | +66.7% |
| Q2 2017 | $832,000 | +32.1% | 8,025 | 0.0% | 0.01% | +20.0% |
| Q1 2017 | $630,000 | +75.0% | 8,025 | 0.0% | 0.01% | +66.7% |
| Q4 2016 | $360,000 | -19.6% | 8,025 | 0.0% | 0.00% | -25.0% |
| Q3 2016 | $448,000 | +11.7% | 8,025 | 0.0% | 0.00% | +33.3% |
| Q2 2016 | $401,000 | +9.0% | 8,025 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $368,000 | -2.6% | 8,025 | +31.0% | 0.00% | 0.0% |
| Q4 2015 | $378,000 | +10.9% | 6,128 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $341,000 | -8.8% | 6,128 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $374,000 | +5.9% | 6,128 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $353,000 | – | 6,128 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|